General information

Which studies are eligible?

  • Multicenter studies of any design
  • Multicenter studies can be submitted with their study design, baseline data, or results
  • Single-center studies only if randomised and results available

Abstract Submission Instructions:

A properly submitted abstract will include the following elements:

  • Title
  • Author(s) and disclosure statement
  • Topic and abstract categories
  • Abstract body (summarise subject in 250 words or less)

You can edit or delete your abstract online at any time before November 20, 2017. If you wish to withdraw your abstract after that date you must inform the ESR Office in writing by email.

Please note that only digital material will be accepted for oral presentations. It can be submitted online prior to ECR 2018 or transferred from the speaker's USB memory stick to a central server onsite at least 3 hours prior to the session. Computers connected to data projectors are provided in each lecture room for the speaker to retrieve the saved data.
 
Detailed notifications of acceptance and guidelines for presentation will be sent by email by the beginning of December 2017.

Presenters of accepted abstracts (no first or second authors) who have paid their ESR membership fee by August 31, 2017, can attend ECR 2018 for a reduced fee of EUR 300,-

Please note that there will be no refund for fees already paid.

Submission steps

1. Terms and conditions
Complete the required terms and conditions by clicking on the appropriate boxes.

2. Topic
Select the appropriate subspecialty (topic).

3. Title
Please keep titles as long as necessary but as short as possible (max. 160 characters). Titles should all be lower case except for acronyms, proper names (e.g. Doppler, Crohn's) and the first letter. Please spell out any Greek or scientific characters (e.g. beta). Do not use a full stop at the end of the title.

4. Author(s)
Only people that contributed to the work should be listed – gift or ghost authorship is strictly discouraged. Note that the system requires contact information (incl. email address) for each author. Please select the presenter, set the order of authors and check your author block with regard to spelling or special characters.

5. Disclosure statement
It is the policy of the European Congress of Radiology to ensure balance, independence, objectivity, and scientific rigour in the congress programme. Knowledge of possible relationships with sponsors of any kind is mandatory in order to reinforce the educational and scientific message and to relieve any suspicion of a bias. Therefore, the presenting author is asked to submit a Conflict of Interest disclosure on behalf of all authors.

6.  Abstract categories
The four equally weighted keyword columns (Area of Interest, Technique, Procedure, Special Focus) each contain a variety of terms relevant to radiology. Please select the appropriate one(s) from each keyword column in the drop-down menu.

  • Area of Interest: one selection (required), up to three (optional)
  • Technique: up to three (optional)
  • Procedure: up to three (optional)
  • Special Focus: up to three (optional)

 
7.  Projection material
In the "Additional Information" section, it will be required to tick a box stating that you understand that only digital projection material will be allowed.

8. Abstract body
Enter the abstract text by typing or copying and pasting plain text from a prepared document into the appropriate fields. Abstracts should be submitted in a format ready for publication. Please check and avoid any typographic and grammatical errors.
The abstract body (summarise subject in 250 words or less) has to be structured as follows:

  • Purpose: provide a one-sentence statement about why you conducted this clinical trial
  • Ethics committee approval: provide information about review board approval and written informed consent
  • Methods and Materials: provide sufficient information about the study methods and state whether it was a randomised or non-randomised study and at how many sites the trial was conducted
  • Results: succinctly describe the most important results in regards to the primary outcomes of the trial
  • Limitations: provide a one-sentence statement about the most important limitations of the trial
  • Conclusion: conclude with the clinical implications that arise from the study results
  • Funding for this study: provide information about the funding source or state that there was no funding from industry and/or a funding agency

9. Summary page
When the abstract submission process is complete, a summary page is displayed. This page includes the abstract control number and all details of your submission. Please review this summary carefully to ensure that it is correct. If it is not, please edit accordingly.

10. Confirmation
Optional: a confirmation of your submission can be emailed to you and to your co-authors.

Contact

General information can be obtained through the ESR Office:

Neutorgasse 9, 1010 Vienna, Austria

Phone: (+43/1) 533 40 640 – ext. 46, Fax: (+43/1) 533 40 649

Email: manuela.gewessler@myESR.org
 

ESR Supporting Members

Gold